|
|
|
Volumn 8, Issue 3 Suppl, 2002, Pages
|
|
Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALMOTRIPTAN;
INDOLE DERIVATIVE;
SEROTONIN AGONIST;
TRYPTAMINE DERIVATIVE;
COMPARATIVE STUDY;
COST CONTROL;
DRUG COST;
ECONOMICS;
HEALTH INSURANCE;
HUMAN;
MIGRAINE;
OUTCOME ASSESSMENT;
PATHOPHYSIOLOGY;
PATIENT SATISFACTION;
QUALITY OF LIFE;
REVIEW;
UNITED STATES;
COST CONTROL;
DRUG COSTS;
HUMANS;
INDOLES;
MANAGED CARE PROGRAMS;
MIGRAINE DISORDERS;
OUTCOME ASSESSMENT (HEALTH CARE);
PATIENT SATISFACTION;
QUALITY OF LIFE;
SEROTONIN AGONISTS;
TRYPTAMINES;
UNITED STATES;
|
|
EID: 0036480242
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (46)
|
